NewGenIvf (NIVF) Accounts Payables (2022 - 2025)

NewGenIvf has disclosed Accounts Payables across 4 years of filings, most recently posting $90388.0 for Q4 2025.

• In Q4 2025, Accounts Payables fell 46.12% year-over-year to $90388.0; the TTM figure through Dec 2025 stood at $90388.0 (down 46.12% YoY), while the FY2025 annual figure was $90388.0, down 46.12% from the prior year.
• Accounts Payables slipped to $90388.0 in Q4 2025, from $797.7 billion in the prior quarter.
• Over the last five years, Accounts Payables for NIVF reached as high as $797.7 billion in Q3 2025 and fell as low as $64077.0 in Q4 2022.
• The 4-year median for Accounts Payables is $170194.0 (2023), against an average of $133.0 billion.
• Annual changes were most pronounced in 2023 — Accounts Payables surged 169.4% — and 2025, when it slumped 46.12%.
• A 4-year view of Accounts Payables shows it stood at $64077.0 in 2022, then surged by 169.4% to $172626.0 in 2023, then decreased by 2.82% to $167762.0 in 2024, then plunged by 46.12% to $90388.0 in 2025.
• According to Business Quant data, Accounts Payables over the past three periods registered $90388.0, $797.7 billion, and $876253.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.